Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Autoimmune Disorders

Free Subscription 31.08.2026 1 BMC Neurol 2 Brain 2 Diabet Med 1 J Autoimmun 4 J Neurol 4 Mult Scler 1 Neurology 1 PLoS Biol 2 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. KOLSCHE T, Hagler R, Huntemann N, Masanneck L, et al
   Investigating the role of serum IL-6 in predicting outcomes of b-cell depleting therapy in multiple sclerosis: a retrospective cohort study.
   BMC Neurol. 2026;26:536.
   PubMed         Abstract available
   
   

   
   Brain

2. FOSTER MA, Wade C, Ford HL, Schmierer K, et al
   Diagnosing multiple sclerosis: implementation and unintended effects of the 2024 McDonald criteria.
   Brain. 2026 Aug 28:awag293. doi: 10.1093.
   PubMed         Abstract available
   
   
3. GRUT V, Ingvarsson J, Bistrom M, Jons D, et al
   Lytic Epstein-Barr virus infection and emerging autoantibodies precede multiple sclerosis prodrome.
   Brain. 2026 Aug 22:awag283. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Diabet Med

4. DESAI SS, Malik MMUD
   Comment on 'Improved prediction of symptomatic type 1 diabetes using a luciferase-based assay to measure (pro) insulin autoantibodies'.
   Diabet Med. 2026 Aug 28:e70462. doi: 10.1111/dme.70462.
   PubMed        
   
   
5. WYATT RC, Brigatti C, Grace SL, Williams CL, et al
   In response to comment on improved prediction of symptomatic type 1 diabetes using a luciferase-based assay to measure (pro) insulin autoantibodies.
   Diabet Med. 2026 Aug 28:e70471. doi: 10.1111/dme.70471.
   PubMed        
   
   

   
   J Autoimmun

6. LOU H, Zhang M, Zhang B, Lu Q, et al
   Multimodal computational framework resolves B cell maturation in autoimmunity and ageing.
   J Autoimmun. 2026;163:103609.
   PubMed         Abstract available
   
   

   
   J Neurol

7. JIANG M, Rubin M, Storelli L, Grosselle M, et al
   Subjective sleep disturbances are associated with reduced MRI-derived perivascular-space diffusivity in multiple sclerosis.
   J Neurol. 2026;273:538.
   PubMed         Abstract available
   
   
8. DE MAURO A, Cortese R, Fadda G, De Stefano N, et al
   Central vein sign and paramagnetic rim lesions in pediatric-onset multiple sclerosis: a systematic review and meta-analysis.
   J Neurol. 2026;273:540.
   PubMed         Abstract available
   
   
9. CRISCUOLO V, Nicolella V, Polito C, Sirica R, et al
   Real-world Roche Elecsys((R)) and Fujirebio Lumipulse((R)) inter-platform comparability and clinical validation of plasma neurofilament light chain in multiple sclerosis.
   J Neurol. 2026;273:546.
   PubMed         Abstract available
   
   
10. PENG HH, Nhu NT, Hou WH
    Effectiveness of vestibular rehabilitation in patients with multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials.
    J Neurol. 2026;273:553.
    PubMed         Abstract available
    
    

    
    Mult Scler

11. GROMISCH ES, Foley FW, Wagshul ME, Holtzer R, et al
    Affective reserve in older adults with and without multiple sclerosis: A residual-based approach.
    Mult Scler. 2026 Aug 28:13524585261480508. doi: 10.1177/13524585261480508.
    PubMed         Abstract available
    
    
12. GILMORE S, Poole S, Henderson K, Sisodia N, et al
    Persistent differences in initial diagnostic trajectory for Black and Hispanic individuals presenting with multiple sclerosis between 2020 and 2023.
    Mult Scler. 2026 Aug 23:13524585261475041. doi: 10.1177/13524585261475041.
    PubMed         Abstract available
    
    
13. SWETLIK C, Parikh S, Abrams A, Bhayana K, et al
    Taking another look: LBSL diagnosed in adulthood masquerading as multiple sclerosis.
    Mult Scler. 2026 Aug 22:13524585261477212. doi: 10.1177/13524585261477212.
    PubMed         Abstract available
    
    
14. MONTOBBIO N, Bovis F, Hofer L, Haring DA, et al
    A community-validated tool for clinical outcome calculation in multiple sclerosis: Consensus development and scenario-specific recommendations.
    Mult Scler. 2026 Aug 22:13524585261478492. doi: 10.1177/13524585261478492.
    PubMed         Abstract available
    
    

    
    Neurology

15. HACOHEN Y, Androdias G, Arrambide G, Bruijstens AL, et al
    De-Escalating and Discontinuing Immunotherapies in Patients With NMOSD and MOGAD.
    Neurology. 2026;107:e218482.
    PubMed         Abstract available
    
    

    
    PLoS Biol

16. CUNHA C, Inacio D, Romero PV, Pais AT, et al
    A microRNA atlas of CD4+ T cell subsets in experimental autoimmune encephalomyelitis identifies regulators of disease pathogenesis.
    PLoS Biol. 2026;24:e3003271.
    PubMed         Abstract available
    
    

    
    PLoS One

17. CHAIPRASERT A, Han P, Laomettachit T, Ruengjitchatchawalya M, et al
    Phycocyanobilin: A potential bioactive compound from Arthrospira platensis targeting LYN protein associated with systemic lupus erythematosus.
    PLoS One. 2026;21:e0357093.
    PubMed         Abstract available
    
    
18. SUN B, Lu Y, Liu W, Wang C, et al
    Systems pharmacology reveals type I interferon and myeloid-like B cell reprogramming as candidate druggable axes in antiphospholipid syndrome.
    PLoS One. 2026;21:e0349155.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

19. ARCO-HIERVES A, Pamboukas K, Bilonda Mutala L, Borowski LS, et al
    Loss of epitranscriptomic mitochondrial RNA surveillance drives epithelial type I interferon and inflammation in autoimmunity.
    Proc Natl Acad Sci U S A. 2026;123:e2534325123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum